BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2422474)

  • 1. Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    J Cardiovasc Pharmacol; 1986; 8(2):346-57. PubMed ID: 2422474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and regional pre- and post-junctional sympathoinhibitory effect of perindopril in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    J Hypertens Suppl; 1986 Oct; 4(3):S513-6. PubMed ID: 3023592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B; Richer C; Giudicelli JF
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.
    Moreau N; Richer C; Vincent MP; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):126-34. PubMed ID: 7690084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
    Richer C; Mulder P; Doussau MP; Gautier P; Giudicelli JF
    Br J Pharmacol; 1990 Jul; 100(3):557-63. PubMed ID: 2390680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
    Richer C; Domergue V; Vincent MP; Giudicelli JF
    Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral alpha 2-adrenoceptor-mediated sympathoinhibitory effects of mivazerol.
    Richer C; Gobert J; Noyer M; Wülfert E; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(6):529-37. PubMed ID: 8985723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of captopril and enalapril on regional vascular alpha-adrenergic receptor reactivity in SHR.
    Richer C; Doussau MP; Giudicelli JF
    Hypertension; 1984; 6(5):666-74. PubMed ID: 6094343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats].
    Moreau N; Richer C; Vincent MP; Giudicelli JF
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1269-74. PubMed ID: 8129542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite influences of hypertension and diabetes mellitus on pressor responses induced by different alpha-adrenoceptor agonists and angiotensin II in pithed rats.
    Beenen OH; Mathy MJ; Pfaffendorf M; van Zwieten PA
    Blood Press; 1996 Jan; 5(1):57-63. PubMed ID: 8777475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
    Scalbert E; Richer C; Giudicelli JF
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsynaptic alpha adrenoceptors and attenuation of vascular sympathetic responses in SHRs by captopril and enalapril.
    Richer C; Doussau MP; Giudicelli JF
    Eur Heart J; 1983 Nov; 4 Suppl G():55-60. PubMed ID: 6319143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
    Bergström G; Johansson I; Stevenson KM; Kett MM; Anderson WP
    Hypertension; 1998 Apr; 31(4):1007-13. PubMed ID: 9535428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
    Giudicelli JF; Richer C; Richard C; Thuillez C
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
    Campbell DJ; Duncan AM; Kladis A; Harrap SB
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of perindopril: experimental pharmacology.
    Barthelmebs M; Devissaguet M; Imbs JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():471-86. PubMed ID: 2691126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
    Richer C; Doussau MP; Giudicelli JF
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and regional hemodynamic interactions of perindopril and nitrendipine in the spontaneously hypertensive rat.
    Scalbert E; Narcisse G; Abdon D; Fauchère JL; Santoni JP
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):676-83. PubMed ID: 1691399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.